SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back


Title
: Recognizing and Managing Heart Failure in Primary Care
Activity/Course #:
: RealCME723726
Cost:
: Free
Release/Start Date:
: Oct 20 2016
Expiration Date:
: Oct 19 2017
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers
Format:
: Patient Case Study
Estimated Time To Complete CME Activity:
: 1.0 Hours
Credit(s):
: 0
Hardware/Software Requirements:
Heart failure (HF) is a growing problem in the United States, affecting an estimated 5.1 million Americans ≥20 years of age. The disease is a cause for even greater concern among African Americans, in whom the relative incidence is 50% higher compared with the general population. Despite the availability of various treatment options, HF care is suboptimal in clinical practice. Provider barriers include knowledge barriers, diagnostic challenges, pharmacological concerns, communication issues, and personal factors. Early detection of HF can improve outcomes, but the symptoms and signs of HF are often difficult to identify because they are frequently confused with other disorders or are attributed to aging, obesity, or lack of conditioning. As a result, HF is misdiagnosed or underdiagnosed. HF patients may not receive any intervention or may be undertreated, resulting in a very small number of patients reaching goals and recommended levels of therapy with standard treatments including beta blockers, ACE inhibitors, ARBs, and diuretics.

After many years, new treatment options are available with novel mechanisms of action that can improve outcomes when added to optimized, guideline directed medical therapy. This program will raise awareness of risk factors for heart failure including African Americans and other ethnic minorities, discuss the role of biomarkers, help participants understand the indications for new therapies, and demonstrate how to appropriately incorporate them into clinical practice.

This activity utilizes a flipped classroom design. This begins with a foundational self-study followed by an online live webinar, which will be available on-demand after the live event, where all participants will have the opportunity to interact with the faculty and other learners.

Learning Objectives
After completing this activity, the reader should be better able to:

  1. Know the risk factors for heart failure and the role of biomarkers in diagnosis and treatment.
  2. Describe pathophysiologic factors contributing to increased risk of heart failure among African Americans and other ethnic minorities.
  3. Identify approaches to facilitate early recognition of heart failure.
  4. Manage heart failure using the most recent clinical evidence.

How To Obtain Your CME Certificate

  1. Read the learning objectives and faculty disclosures.
  2. Participate in the activity.
  3. Complete the post-test and activity evaluation.
  4. Physicians who successfully complete the post-test and evaluation will receive CME credit.
  5. Nurse Practitioners who successfully complete the post-test and evaluation will receive AANP CE credit.
  6. You must score 60% or higher on the post-test to receive credit for this activity.
  7. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
Sponsored and Certified By
National Association for Continuing Education & Association of Black Cardiologists, Inc.
Accreditation Designation Statement
The Association of Black Cardiologists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Association of Black Cardiologists designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Academy of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1.0 hrs contact hours of continuing education (which includes 0.25 hours of pharmacology)
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the National Association for Continuing Education to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the National Association for Continuing Education are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure is provided below.

Barbara Hutchinson, MD, PhD, FACC, faculty, serves as a speaker for Novartis.

Anekwe Onwuanyi, MD, faculty, serves as a speaker for Novartis.

Planning Committee
Gregg Sherman, MD, has no real or apparent conflicts of interest to report.

Harvey Parker, PhD, has no real or apparent conflicts of interest to report.

Josh Kilbridge has no real or apparent conflicts of interest to report.
Commercial Support
This activity is supported by educational funding provided by Novartis Pharmaceuticals.